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Abstract
Functioning is recognized as an important study outcome in
rheumatoid arthritis (RA). The Comprehensive ICF Core Set for
RA is an application of the International Classification of
Functioning, Disability and Health (ICF) of the World Health
Organisation with the purpose of representing the typical
spectrum of functioning of patients with RA. To strengthen the
patient perspective, persons with RA were explicitly involved in
the validation of the Comprehensive ICF Core Set for RA using
qualitative methodology. The objective of the study was twofold:
to come forward with a proposal for the most appropriate
methodology to validate Comprehensive ICF Core Sets from the
patient perspective; and to add evidence to the validation of the
Comprehensive ICF Core Set for RA from the perspective of
patients. The specific aims were to explore the aspects of
functioning and health important to patients with RA using two
different focus group approaches (open approach and ICF-
based approach) and to examine to what extent these aspects
are represented by the current version of the Comprehensive
ICF Core Set for RA. The sampling of patients followed the
maximum variation strategy. Sample size was determined by
saturation. The focus groups were digitally recorded and
transcribed verbatim. The meaning condensation procedure
was used for the data analysis. After qualitative data analysis, the
resulting concepts were linked to ICF categories according to
established linking rules. Forty-nine patients participated in ten
focus groups (five in each approach). Of the 76 ICF categories
contained in the Comprehensive ICF Core Set for RA, 65 were
reported by the patients based on the open approach and 71
based on the ICF-based approach. Sixty-six additional
categories (open approach, 41; ICF-based approach, 57) that
are not covered in the Comprehensive ICF Core Set for RA were
raised. The existing version of the Comprehensive ICF Core Set
for RA could be confirmed almost entirely by the two different
focus group approaches applied. Focus groups are a highly
useful qualitative method to validate the Comprehensive ICF
Core Set for RA from the patient perspective. The ICF-based
approach seems to be the most appropriate technique.
Introduction
Functioning is recognized as an important study outcome in
rheumatoid arthritis (RA). The number of clinical studies
addressing functioning as a study endpoint in patients with RA
has steadily increased during the past decade [1]. These
investigations have predominantly been guided by the medical
perspective, from which the measurement of functioning and
health is required to evaluate the patient-relevant outcomes of
an intervention and from which functioning and health are seen
primarily as a consequence of the disease [2]. Many of these
investigations include patient-oriented instruments, for exam-
ple, patient and proxy self-reports on health status, quality of
life, and health preferences. In rheumatology, the Health
Assessment Questionnaire Disability Index (HAQ [3]) and the
ICF = International Classification of Functioning, Disability and Health; RA = rheumatoid arthritis; WHA = World Health Assembly; WHO = World 
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Arthritis Impact Measurement Scales (AIMS2 [4]), which can
be considered a generic instrument specific for RA, are widely
used.
These instruments have also been developed according to the
medical perspective and in line with the current concept in out-
comes and quality-of-life research of condition-specific meas-
ures [5], that is, they are based on the assumption that
different conditions are associated with salient patient prob-
lems in functioning. The individual influence of the environment
and personal factors is, however, rarely taken into account
[6,7]. In addition, widely used RA-specific health-status meas-
ures, like the Health Assessment Questionnaire Disability
Index, mainly address activities far more than participation [8].
However, patients' experiences of functioning are determined
by their interaction with the environment and their own per-
sonal characteristics and not only by the health condition [9-
12]. RA is also very much associated with the inability to con-
tinue working, ultimately leading to the experience of restric-
tion in participation [13-16]. Thus, a very comprehensive
approach is required when addressing RA.
The bio-psycho-social model of Functioning, Disability and
Health of the World Health Organization (WHO) [17] estab-
lishes the basis for a more comprehensive description of the
experience of patients suffering from determined disease.
Based on this model, functioning, with its components 'Body
Functions', 'Body Structures' and 'Activities and Participation',
is seen in relation to the health condition under consideration,
as well as 'Personal Factors' and 'Environmental Factors' (Fig-
ure 1) [17]. Functioning denotes the positive aspects, and dis-
ability the negative aspects of the interaction between an
individual with a health condition and the contextual factors
(Environmental Factors and Personal Factors) of that
individual.
This bio-psycho-social view guided the development of the
International Classification of Functioning, Disability and
Health (ICF), which was approved by the World Health
Assembly (WHA) in May 2001. As the ICF has been devel-
oped in a worldwide, comprehensive consensus process over
the past few years and was endorsed by the WHA as a mem-
ber of the WHO Family of International Classifications, it is
likely to become the generally accepted framework to describe
functioning and health. The ICF is intended for use in multiple
sectors that, besides health, include education, insurance,
labour, health and disability policy, statistics, and so on. In the
clinical context, it is intended for use in needs assessment,
matching interventions to specific health states, rehabilitation
and outcome evaluation. With the ICF, not only an etiologically
neutral framework, but a globally agreed-on language and a
classification is available to describe functioning on both the
individual and population levels and from both the patient per-
spective and that of the health professionals. The ICF contains
more than 1,400 so-called ICF categories, each allotted to the
named components in the bio-psycho-social model with the
exception of the component Personal Factors, which has not
yet been classified. Each ICF category is denoted by a code
composed by a letter that refers to the components of the clas-
sification (b, Body Functions; s, Body Structures; d, Activities
and Participation; e, Environmental Factors) and is followed by
a numeric code starting with the chapter number (one digit),
followed by the 2nd level (two digits) and the 3rd and 4th lev-
els (one digit each) (Figure 1).
All member states of the WHO are now called upon to imple-
ment the ICF in multiple sectors that, besides health, include
education, insurance, labour, health-and-disability policy, sta-
tistics, and so on. However, the ICF has to be tailored to suit
these specific applications [18]. In the clinical context, the
main challenge is the length of the classification with its over
1,400 categories. Mainly to address the issue of feasibility
regarding the number of categories, ICF Core Sets have been
developed in a formal decision making and consensus-based
process integrating evidence gathered from preliminary stud-
ies for a number of the most burdensome, chronic health con-
ditions, including RA [19]. The preliminary studies included a
Delphi exercise [20], a systematic review [21] on outcomes
used in randomized clinical trials, which represents the view of
researchers performing studies, and an empirical data collec-
tion, using the ICF checklist [22]. Based on these studies, rel-
evant ICF categories were identified. The lists of these
identified categories represent the starting point of the deci-
sion-making and consensus process that took place at the
consensus conference. The ICF Core Sets for patients with a
determined health condition represent a selection of ICF cate-
gories out of the whole classification that can serve as minimal
standards for the reporting of functioning and health for clinical
studies and clinical encounters (Brief ICF Core Set) or as
standards for multiprofessional, comprehensive assessment
(Comprehensive ICF Core Set) under consideration of influen-
tial Environmental Factors. Since the ICF Core Sets address
aspects within all the components of the ICF (Body Functions,
Body Structures, Activities and Participation, Environmental
Factors) they present a broad, condition-specific perspective
that may reflect the whole health experience of patients. The
current version of the Comprehensive ICF Core Set for RA
includes 76 categories at the 2nd, 8 categories at the 3rd, and
12 categories at the 4th level of the classification. Regarding
the 2nd level of the classification, 15 categories pertain to the
component Body Functions, 8 categories to the component
Body Structures, 32 categories to the component Activities
and Participation and 21 categories to the component Envi-
ronmental Factors [23]. The Comprehensive ICF Core Set for
RA describes the typical spectrum of problems in functioning
among patients with RA encountered in comprehensive
assessments or in clinical studies. Additionally, it provides an
ideal basis from which to define theoretically sound models of
functioning and disability in patients with RA.Available online http://arthritis-research.com/content/8/4/R84
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The Comprehensive ICF Core Set for RA is now undergoing
worldwide testing and validation using a number of
approaches, including an international multicenter validation
study and validation from the perspective of health profession-
als. One key aspect is the validation from the patient perspec-
tive. While the patient perspective has been implicitly included
in the development of ICF Core Sets [22], the patients now
will be explicitly involved in the process of the development
and validation of ICF Core Sets. As standards of functioning
and health in research and clinical practice, the ICF Core Sets
have to show that they address the perspective of those who
experience the disease.
Qualitative methodology provides the possibility to explore the
perspective of those who experience a health problem, that is,
the so-called patient perspective [24,25]. Qualitative methods
are now widely used and increasingly accepted in health
research and health-related sciences [26-28]. One of the
most broadly used techniques in qualitative research is the
focus group methodology [29-31]. Focus groups are "care-
fully planned series of discussions designed to obtain percep-
tions on a defined area of interest in a permissive, non-
threatening environment" [32]. They are especially useful for
studies that involve complex issues that entail many levels of
feeling and experience [33]. "The basic goal in conducting
focus groups is to hear from the participants about the topics
of interest to the researcher" [34]. The idea behind this meth-
odology is that group processes can help people to explore
and clarify their views [35]. The non-directive nature of focus
groups affords participants an opportunity to comment,
explain, disagree and share experiences and attitudes [36].
The objective of the present study was twofold: first, to come
forward with a proposal for the most appropriate focus group
approach to validate Comprehensive ICF Core Sets from the
patient perspective; and second, to add evidence to the vali-
dation of the Comprehensive ICF Core Set for RA from the
perspective of patients with RA based on a group of German
patients. The specific aims were to explore the aspects of
functioning and health important to patients with RA using two
different focus group approaches and to examine to what
extent these aspects are represented by the current version of
the Comprehensive ICF Core Set for RA.
Materials and methods
Design
We conducted a qualitative study with patients with RA using
the focus group methodology. Two different focus group
approaches were used, an open approach and an ICF-based
approach. In the open approach, open-ended questions ask-
ing the patients to name their problems in Body Functions,
Body Structures, and Activities and Participation were used.
The patients were additionally asked about Environmental Fac-
tors (barriers and facilitators) influencing their everyday life
(Table 1). In the ICF-based approach, each of the titles of the
ICF chapters from which categories are included in the Com-
prehensive ICF Core Set for RA were presented. For each of
the presented chapters, open-ended questions on possible
problems in each of the life areas that the ICF chapters repre-
sent were used (Table 1). Finally, the patients were asked
whether they thought anything was missing in the Comprehen-
sive ICF Core Set for RA.
The study was approved by the Ethics Commission of the Lud-
wig-Maximilian University, Munich.
Participants
All patients with RA diagnosed according to the revised Amer-
ican College of Rheumatology Criteria [37] who had been
treated in the day clinic of the Department of Physical Medi-
cine and Rehabilitation of the Ludwig-Maximilian University in
Munich at any time since 2001 were contacted by mail and
asked whether they would like to participate in the study. Par-
ticipants were then selected from the list of all willing patients
by the maximum variation strategy [38] based on the criteria
disease duration and age group. Further participants were
recruited from the German self-help service ('Deutsche
Rheuma-Liga e.V.'). The group size was set at a maximum of
seven persons to represent different opinions and facilitate
interactions. Patients who participated in the focus groups
gave written informed consent according to the Declaration of
Helsinki 1996.
Sample size
The sample size was determined by saturation [38]. Saturation
refers to the point at which an investigator has obtained suffi-
cient information from the field [32] (see Data analysis: satura-
tion of data).
Data collection
All groups were conducted in a non-directive manner by the
same moderator (MC) and one group assistant (EA, 'open
approach'; BK, 'ICF-based approach'). Moderator and group
assistants were psychologists with expertise in the ICF and in
conducting group processes.
The focus groups were conducted according to focus group
guidelines, including open-ended questions and further
instructions (for example, introduction, procedure of the ses-
sion, technical aspects). At the beginning of each focus group,
the procedure of the session was explained, and the concept
of the ICF was presented in lay terms to all participants. Then
one of the two different focus group approaches was per-
formed (open approach or ICF-based approach). The open-
ended questions or the titles of the chapters (ICF-based
approach) were presented visually to the participants by a
Microsoft PowerPoint presentation. At the end of each focus
group, a summary of the main results was given back to the
group to enable the participants to verify and amend emergent
issues.Arthritis Research & Therapy    Vol 8 No 4    Coenen et al.
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The focus groups were digitally recorded and transcribed ver-
batim with an Olympus DSS system. The assistants observed
the process within the group. Additionally, they filled in field
notes according to a standardized coding schema. Field notes
refer descriptive observations of the group interaction and of
the topics of discussion. After each focus group a debriefing
with moderator and assistant took place to review the course
of the focus group.
The two focus group approaches were conducted alternately.
Data analysis
Qualitative analysis
The meaning condensation procedure [39] was used for the
qualitative analysis of data. In the first step, the transcripts of
the focus groups were read through to get an overview over
the collected data. In the second step, the data were divided
into units of meaning, and the theme that dominated a meaning
unit was determined. A meaning unit was defined as a specific
unit of text either a few words or a few sentences with a com-
mon theme [40]. Therefore, a meaning unit division did not fol-
low linguistic grammatical rules. Rather, the text was divided
where the researcher discerned a shift in meaning [39]. In the
third step, the concepts contained in the meaning units were
identified. A meaning unit could contain more than one
concept.
Linking to the ICF
According to the purpose of multiple coding, the identified
concepts were linked to the categories of the ICF by two
health professionals (open approach, MC and EA; ICF-based
approach, MC and BK) based on established linking rules
[6,7], which enable linking concepts to ICF categories in a sys-
tematic and standardized way (Table 2). According to these
linking rules, health professionals trained in the ICF are
advised to link each concept to the ICF category representing
this concept most precisely. One concept could be linked to
one or more ICF categories, depending on the number of
themes contained in the concept. Consensus between the
two health professionals was used to decide which ICF cate-
gory should be linked to each identified concept. In case of a
disagreement, a third person trained in the linking rules was
consulted. In a discussion led by the third person, the two
health professionals that linked the concepts stated their pros
and cons for the linking of the concept under question to a
specific ICF category. Based on these statements, the third
person made an informed decision.
Saturation of data
In this study saturation was defined as the point during data
collection and analysis when the linking of the concepts of two
consecutive focus groups reveals no additional 2nd level cat-
egories of the Comprehensive ICF Core Set for RA with
respect to previous focus groups. Saturation was checked
separately for the two approaches.
Confirmation of the ICF categories contained in the 
Comprehensive ICF Core Set for RA
An ICF category of the Comprehensive ICF Core Set for RA
was regarded as confirmed if the identical or a similar category
emerged from the focus groups (for example, s299 eye, ear
and related structures, unspecified confirmed by s230 struc-
tures around eye). Since the ICF categories are arranged in a
hierarchical code system, the 2nd level categories of the Com-
prehensive ICF Core Set for RA were considered confirmed
when the corresponding 3rd or 4th level category of which
they were a member had been named by the patients.
Accuracy of the analysis
To audit the accuracy of the analysis, 15% of the transcribed
text was randomly selected, analyzed according to the mean-
ing condensation procedure, and linked to the ICF by two
health professionals (MC and TS) as a peer review. This proc-
ess was performed in addition to the process described in the
section 'Linking to the ICF'. The degree of agreement between
the two investigators regarding the identified and linked con-
cepts in this random selected text was calculated by kappa
statistic with 95%-bootstrapped confidence intervals [41,42].
The values of the kappa coefficient generally range from 0 to
1, where 1 indicates perfect agreement and 0 indicates no
additional agreement beyond what is expected by chance
alone. The data analysis was performed with SAS for windows
V9.1 (SAS Institute Inc., Cary, NC, USA).
Results
Description of the focus groups
A total of 49 participants were included in the focus groups
(open approach, n = 25; ICF-based approach, n = 24). Partic-
ipants' characteristics are summarized in Table 3. Ten focus
groups with five groups in each approach were conducted.
The focus group sessions lasted from about fifty minutes to
two hours, including a short break. Regarding the categories
of the Comprehensive ICF Core Set for RA, saturation of data
was reached in both approaches after conducting five focus
groups (Figure 2).
Table 1
Open-ended questions of the focus groups
Open-ended questions
If you think about your body and mind, what does not work the way it 
is supposed to?
If you think about your body, in which parts are your problems?
If you think about your daily life, what are your problems?
If you think about your environment and your living conditions,:
what do you find helpful or supportive?
what barriers do you experience?Available online http://arthritis-research.com/content/8/4/R84
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Qualitative analysis and linking
A total of 1,900 relevant concepts were identified in the two
approaches (open approach, n = 897; ICF-based approach, n
= 1,003). These concepts were linked to 342 different ICF
categories. For 155 of the 342 categories at the 3rd and 4th
level of the classification, the corresponding 2nd level catego-
ries were considered (n = 66). Thus, the concepts were linked
to a total of 253 2nd level categories. Fifty-two concepts
named by the participants were more specific than the corre-
sponding most specific ICF category (for example, jaw joint,
problems with climbing upstairs). Regarding the categories of
the chapter 'sensory functions and pain' (b2), for example, the
participants reported several issues according to the pain
quality (pressure pain, rest pain, stabbing pain), which are not
specifically covered by the existing ICF categories. Therefore,
all these concepts referring to different qualities of pain were
linked to the ICF category 'b280 sensation of pain'.
Thirty-two concepts could not be linked to ICF categories (for
example, quality of life in general, aspects of coping, disease
management, time-related aspects, and variability of function-
ing). Fifteen of them could be allotted to the component Per-
sonal Factors, which has not yet been classified.
Confirmation of the Comprehensive ICF Core Set for RA
In total, 74 out of the 76 2nd level categories included in the
Comprehensive ICF Core Set for RA were confirmed by the
two focus group approaches (open approach, n = 65; ICF-
based approach, n = 71). All 2nd level categories of the com-
ponents Body Functions (n = 15) and Body Structures (n = 8)
that are included in the Comprehensive ICF Core Set for RA
were reported by the patients in the ICF-based focus group
approach (Tables 4 to 7; categories in bold typeface).
Additional categories
Sixty-six 2nd level additional categories (open approach, n =
41; ICF-based approach, n = 57) that are not included in the
Figure 1
The bio-psycho-social model of functioning, disability and health The bio-psycho-social model of functioning, disability and health.Arthritis Research & Therapy    Vol 8 No 4    Coenen et al.
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current version of the Comprehensive ICF Core Set for RA
were identified in the focus groups (Tables 4 to 7). Most of the
additional categories derive from the component Body Func-
tions (open approach, n = 19; ICF-based approach, n = 29)
followed by Environmental Factors (open approach, n = 15;
ICF-based approach, n = 16). Five additional categories in the
open approach and eight additional categories in the ICF-
based approach were reported by the participants as related
to the component Activities and Participation. Two and four
additional categories from the component Body Structures
were reported in the open and the ICF-based approach,
respectively.
Accuracy of the analysis
The kappa coefficient for the agreement between the two
investigators (peer review) was 0.66. The 95%-bootstrapped
confidence interval, which indicates the precision of the esti-
mated kappa coefficient, was 0.61 to 0.73.
Discussion
The current version of the Comprehensive ICF Core Set for
RA could be confirmed almost entirely from the patient per-
spective by the two different focus group approaches applied
(open approach and ICF-based approach). This study also
confirmed relevant outcomes of treatment in RA from the
patient perspective (for example, pain, stiffness, fatigue, mobil-
ity, muscle strength, getting social support) [24,43,44]. How-
ever, some issues emerged from the patient perspective that
have not yet been covered by the Comprehensive ICF Core
Set for RA or even by the ICF classification. ICF categories of
the Comprehensive ICF Core Set for RA not reported by the
patients were 'd570 looking after one's health' and 'e360
other professionals (support and relationship)'.
Table 2
Scheme of the qualitative data analysis
Transcription Meaning unit ICF category
Moderator: If you think about your body, what functional 
problems do you have?
Patient A: I used to go to sports very often. Now I can't 
anymore. I even had to quit swimming
Restriction of sports Quit swimming d9201 sports d4554 swimming
Patient B: Exactly! I also had to quit swimming.
Patient C: I can no longer cycle. (...) Quit cycling d4750 driving human-powered 
transportation
Moderator: If you think about your body, where are your 
biggest problems?
Patient C: Toes, ankle joints, knee joints, fingers Toes
Ankle joints
s7502 structure of ankle & foot
s75021 ankle joint & joints of foot and toes
Knee joints s75011 knee joint
Fingers s7302 structure of hand
Patient A: What bothers me are my wrists. (...) Wrists s73021 joints of hand and fingers
The transcription undergoes qualitative analysis to derive a meaning unit that is then linked to an International Classification of Functioning, 
Disability and Health (ICF) category.
Table 3
Characteristics of participants and focus groups
Characteristics of participants and 
focus groups
Focus groups Total
Open approach ICF-based approach
Number of participants (n)2 5 2 4 4 9
Mean age, year (range) 59 (24–81) 54 (35–75) 57 (24–81)
Gender (% female) 88 83 86
Mean disease duration, year (range) 16 (4–38) 15 (3–56) 15 (3–56)
Number of focus groups (n)5 5 1 0
Mean session duration, 
hours:minutes (range)
1:09 (0:52–1:15) 1:35 (1:17–2:06) 1:22 (0:52–2:06)
ICF, International Classification of Functioning, Disability and Health.Available online http://arthritis-research.com/content/8/4/R84
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Table 4
Body Functions (b): patients' reporting of ICF categories (2nd level)
ICF categories Reported by patients
Code Title Open approach ICF-based approach
b126 Temperament and personality functions Yes Yes
b130 Energy and drive functions Yes Yes
b134 Sleep functions Yes Yes
b140 Attention functions Yes Yes
b147 Psychomotor functions Yes Yes
b152 Emotional functions Yes Yes
b160 Thought functions Yes Yes
b180 Experience of self and time functions Yes
b210 Seeing functions Yes Yes
b215 Functions of structures adjoining the eye Yes
b220 Sensations associated with the eye and adjoining structures Yes Yes
b230 Hearing functions Yes Yes
b240 Sensations associated with hearing and vestibular function Yes
b250 Taste function Yes
b255 Smell function Yes
b265 Touch function Yes Yes
b270 Sensory functions related to temperature and other stimuli Yes
b280 Sensation of pain Yes Yes
b320 Articulation functions Yes
b410 Heart functions Yes
b430 Haematological system functions Yes Yes
b435 Immunological system functions Yes Yes
b455 Exercise tolerance functions Yes Yes
b460 Sensations associated with cardiovascular and respiratory functions Yes
b510 Ingestion functions Yes Yes
b515 Digestive functions Yes Yes
b520 Assimilation functions Yes
b525 Defecation functions Yes Yes
b530 Weight maintenance functions Yes Yes
b535 Sensations associated with the digestive system Yes
b540 General metabolic functions Yes
b545 Water, mineral and electrolyte balance functions Yes
b610 Urinary excretory functions Yes
b620 Urination functions Yes
b640 Sexual functions Yes
b710 Mobility of joint functions Yes Yes
b715 Stability of joint functions Yes YesArthritis Research & Therapy    Vol 8 No 4    Coenen et al.
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Sixty-six additional 2nd level categories that are not covered in
the current version of the Comprehensive ICF Core Set for RA
were raised. Most of the additional categories belong to the
component Body Functions followed by the component Envi-
ronmental Factors. Some of these additional ICF categories
need special discussion.
It is important to emphasize that several categories were
named by the patients at a higher level of specification than the
2nd level of the ICF. Some of these more specific categories
are included in the Comprehensive ICF Core Set for RA, and
some are not [23]. One of these very specific categories not
included in the Comprehensive ICF Core Set for RA at higher
levels of specification are 'fatigue' and 'fatiguability'. 'Fatigue'
and 'fatiguability' were linked to the 3rd level category 'b1300
energy level' and 'b4552 fatiguability', which belong to the 2nd
level categories 'b130 energy and drive functions' and 'b455
exercise tolerance functions', respectively. Fatigue was also
identified as an area of particular importance to patients with
RA at OMERACT (Outcome Measures in Rheumatoid Arthritis
Clinical Trials) VI [25,45], as patient-relevant outcome in RA
[44,46] and as an adverse effects of medication [47,48]. Our
study might thus suggest that the categories 'b1300 energy
level' and 'b4552 fatiguability' should be specifically and
explicitly included in the Comprehensive ICF Core Set for RA.
This suggestion is strengthened by the findings of an ICF Core
Set validation study deriving individual interviews [49] and val-
idation studies from the health-professionals perspective.
Numerous additional categories were related to side effects of
medication, which are an important issue for satisfaction with
treatment from the patient perspective [24,43,50]. The partic-
ipants of the study explicitly attributed some categories from
the components Body Functions and Body Structures to side
effects. Some of these causal relationships can also be found
in the literature as complications due to medication [51-59] or
as relevant problems from the patient perspective [60,61]. The
question whether ICF categories concerning side effects of
medication should be included in the Comprehensive ICF
Core Set for RA has to be considered carefully. With the
advent of new medications, new side effects may appear. On
one hand, one has to keep in mind that the ICF Core Sets
establish the standards of 'what to measure' in patients with
RA independent of the treatment (one could even say inde-
pendent of 'fashionable treatment'). On the other hand, the
intake of medication and the suffering of side effects belong to
the reality of patients with RA. Perhaps one solution to this
dilemma could be the development of treatment-specific ICF
Core Sets.
Within the component Environmental Factors numerous cate-
gories not included in the current version of the Comprehen-
sive ICF Core Set for RA were reported by the patients. There
is no doubt that social support is an important Environmental
Factor for patients with RA [62]. Several studies pointed out
the relationship and interaction between social support and
disease activity, pain or disability [63-65].
The category 'e165 (financial) assets', which is not included in
the current version of the Comprehensive ICF Core Set for RA,
was reported by the participants in the focus groups and in the
ICF Core Set validation study using individual interviews [49]
as a relevant Environmental Factor. Economic consequences
in relation to income reduction or to loss of paid work due to
physical disability were also found to be an important issue to
patients with RA in the literature [63,66-68]. Within this con-
text, it has to be taken into account that patients with RA in
most countries also have substantial RA-related out-of-pocket
medical expenditures for co-payments for prescribed drugs,
over-the-counter drugs and costs to complementary and alter-
native medicine [69,70].
With both approaches used in this study, we found a broad
range of themes that could be linked to the corresponding cat-
b730 Muscle power functions Yes Yes
b740 Muscle endurance functions Yes
b760 Control of voluntary movement functions Yes Yes
b770 Gait pattern functions Yes Yes
b780 Sensations related to muscles and movement functions Yes Yes
b810 Protective functions of the skin Yes Yes
b820 Repair functions of the skin Yes
b840 Sensation related to the skin Yes
b850 Functions of hair Yes
b860 Functions of nails Yes
International Classification of Functioning, Disability and Health (ICF) categories of the ICF Core Set for rheumatoid arthritis are shown in bold 
typeface.
Table 4 (Continued)
Body Functions (b): patients' reporting of ICF categories (2nd level)Available online http://arthritis-research.com/content/8/4/R84
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egories. Both approaches performed satisfactory results;
however, it is important to mention that some patient-sensitive
issues were only reported in the ICF-based approach, for
example, 'b535 sensations associated with the digestive sys-
tem', 'b610 urinary excretory functions', 'b620 urination func-
tions', 'b640 sexual functions', and 'd530 toileting'. Issues
concerning mood, disease management and coping were
reported in detail in the open approach. Comparing the two
approaches, the ICF-based approach seems to be the appro-
priate technique to confirm the Comprehensive ICF Core Set
for RA, particularly with regard to the coverage of the compo-
nents Body Structures and Body Functions.
In qualitative research and studies with focus group methodol-
ogy, sample sizes typically remain small because intensive
data analysis is required [30,32]. A small sample size with a
diverse range of participants (n = 49) was used to obtain the
required level of rich and meaningful data. According to Curtis
and colleagues [71], the small samples in qualitative research
are studied intensively and typically generate a large amount of
information. By keeping the questions open-ended, the mod-
erator can stimulate useful trains of thought in the participants
that were not anticipated [72]. The focus groups in our study
were composed of four to seven participants. We decided to
include groups with few participants because of the complex-
ity of the topic and the expertise of the participants according
to the literature [73]. With a small group size, each participant
has a greater opportunity to talk, which is reported as an
important aspect for the group dynamics in groups with elderly
and ill participants [30,74].
The characteristics of the sample in this study (gender, age,
disease duration) are comparable to samples in other national
[62,75] and international studies [43,63]. It is important to
mention that several strategies were used to improve and ver-
ify the trustworthiness of the qualitative data. Triangulation was
used to ensure the comprehensiveness of data. We included
different aspects of triangulation by using two approaches to
focus groups (methodological triangulation) and two data ana-
lysts (investigator triangulation: multiple coding) [76,77]. Con-
tinuous data analysis was used according to Pope and
colleagues [78]. Reflexivity was assured by conducting a
research diary for the documentation of memos concerning
Table 5
Body Structures (s): patients' reporting of ICF categories (2nd level)
ICF categories Reported by patients
Code Title Open approach ICF-based approach
s299 Eye, ear and related structures, unspecified (s220)a Yes Yes
s320 Structure of mouth Yes
s410 Structure of cardiovascular system Yes
s530 Structure of stomach Yes Yes
s540 Structure of intestine Yes
s710 Structure of head and neck region Yes Yes
s720  Structure of shoulder region Yes Yes
s730 Structure of upper extremity Yes Yes
s750  Structure of lower extremity Yes Yes
s760 Structure of trunk Yes Yes
s770 Additional musculoskeletal structures related to movement Yes Yes
s810 Structure of areas of skin Yes Yes
s830 Structure of nails Yes
International Classification of Functioning, Disability and Health (ICF) categories of the ICF Core Set for rheumatoid arthritis are shown in bold 
typeface.
Figure 2
Saturation of the qualitative data in the focus groups Saturation of the qualitative data in the focus groups. ICF, International 
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Table 6
Activities and Participation (d): Patients' reporting of ICF categories (2nd level)
ICF categories Reported by patients
Code Title Open approach ICF-based approach
d163 Thinking Yes
d166 Reading Yes
d170 Writing Yes Yes
d210 Undertaking a single task Yes
d230 Carrying out daily routine Yes Yes
d240 Handling stress and other psychological demands Yes
d330 Speaking Yes
d360 Using communication devices and techniques Yes Yes
d410 Changing basic body position Yes Yes
d415 Maintaining a body position Yes Yes
d430 Lifting and carrying objects Yes Yes
d435 Moving objects with lower extremities Yes
d440 Fine hand use Yes Yes
d445 Hand and arm use Yes Yes
d449 Carrying, moving and handling objects, other specified and 
unspecified (d430/d445)a
Yes Yes
d450 Walking Yes Yes
d455 Moving around Yes Yes
d460 Moving around in different locations (d455)a Yes Yes
d465 Moving around using equipment Yes Yes
d470 Using transportation Yes Yes
d475 Driving Yes Yes
d510 Washing oneself Yes Yes
d520 Caring for body parts Yes Yes
d530 Toileting Yes
d540 Dressing Yes Yes
d550 Eating Yes
d560 Drinking Yes
d570 Looking after one's health No No
d610 Acquiring a place to live Yes
d620 Acquisition of goods and services  Yes Yes
d630 Preparing meals Yes Yes
d640 Doing housework Yes Yes
d650 Caring for household objects Yes Yes
d660 Assisting others Yes
d720 Complex interpersonal interactions Yes Yes
d750 Informal social relationships Yes Yes
d760 Family relationships YesAvailable online http://arthritis-research.com/content/8/4/R84
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d770 Intimate relationships Yes Yes
d850 Remunerative employment Yes Yes
d859 Work and employment, other specified and unspecified (d850)a Yes Yes
d910 Community life Yes
d920  Recreation and leisure Yes Yes
International Classification of Functioning, Disability and Health (ICF) categories of the ICF Core Set for rheumatoid arthritis are shown in bold 
typeface. aConfirmation according to similar categories
Table 7
Environmental Factors (e): patients' reporting of ICF categories (2nd level)
ICF categories Reported by patients
Code Title Open approach ICF-based approach
e110 Products or substances for personal consumption Yes Yes
e115 Products and technology for personal use in daily living Yes Yes
e120 Products and technology for personal indoor and outdoor 
mobility and transportation 
Yes Yes
e125 Products and technology for communication Yes Yes
e130 Products and technology for education Yes
e135 Products and technology for employment Yes
e150 Design, construction and building products and technology 
of buildings for public use
Yes Yes
e155 Design, construction and building products and technology 
of buildings for private use
Yes Yes
e160 Products and technology of land development Yes Yes
e165 Assets Yes Yes
e210 Physical geography Yes
e225 Climate Yes Yes
e310 Immediate family Yes Yes
e315 Extended family Yes Yes
e320 Friends Yes Yes
e325 Acquaintances, peers, colleagues, neighbours and community 
members
Yes Yes
e330 People in positions of authority Yes
e340 Personal care providers and personal assistants Yes Yes
e345 Strangers Yes Yes
e350 Domesticated animals Yes Yes
e355 Health professionals Yes Yes
e360 Other professionals No No
e410 Individual attitudes of immediate family members Yes Yes
e420 Individual attitudes of friends Yes Yes
e425 Individual attitudes of acquaintances, peers, colleagues, 
neighbors and community members
Yes Yes
Table 6 (Continued)
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the design, data collection and analysis of the study. Clear
exposition was used to establish guidelines for conducting the
focus groups (including open-ended questions), verbatim tran-
scription, and linking rules [6,7]. Thus, a clear account of meth-
ods of data collection and analysis was assured. Finally, peer
review was used. The kappa coefficient of 0.66 (0.61 to 0.73)
for the accuracy of the peer review is comparable to other
studies reporting kappa statistics about the linking of catego-
ries [49] and can be regarded as 'substantial agreement' [79].
There are also some limitations of this study that need special
mention. The sample consists only of German participants.
We conducted this study as a pilot study to develop an appro-
priate method to validate ICF Core Sets from the patient per-
spective. Our suggestion is that our methods could be used in
similar studies in other countries to establish a cross-cultural
perspective. Secondly, the linking process was performed by
two health professionals according to established linking rules
[6,7]. However, it remains unclear whether other health profes-
sionals would have decided differently. Finally, we followed the
strategy of saturation during data analyses with the criteria of
two consecutive focus groups revealing no additional 2nd
level categories in the Comprehensive ICF Core Set for RA
with respect to previous focus groups. Participants in a sixth
focus group still might report new themes and concepts not
yet reported.
Further research in the context of the development and confir-
mation of ICF Core Sets is needed. The results of this study
will be presented at an international WHO conference and will
be taken into account for the decision on the final version of
the Comprehensive ICF Core Set for RA. In addition, using this
study as a starting point, we are currently conducting further
focus group studies with RA patients in other countries to
implement the international perspective of the ICF Core Sets.
Finally, the results of this study have also influenced the proto-
col that establishes the methods to developing ICF Core Sets.
From now on the collection of data from the patient perspec-
tive will be implemented in the preliminary phase of the devel-
opment of ICF Core Sets [19].
Conclusion
It is extremely important to consider the patient perspective for
the validation of the Comprehensive ICF Core Set for RA. The
existing version of the Comprehensive ICF Core Set for RA
with its selected categories could be confirmed almost entirely
by the two different focus group approaches applied. Focus
groups are a highly useful qualitative method to validate the
Comprehensive ICF Core Set for RA from the patient perspec-
tive. The ICF-based approach, which uses the contents of the
ICF Core Sets to structure the focus groups seems to be the
most appropriate technique. Additional categories not repre-
sented in the Comprehensive ICF Core Set for RA emerged
from the focus groups.
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